Back to Journals » Drug Design, Development and Therapy » Volume 9

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer

Total article views   Abstract views HTML views PDF downloads Totals
8,903 Dovepress* 6,101 1,862+ 1,576 7,963
PubMed Central* 0 940 414 940
Totals 6,101 2,802 1,990 8,903
*Since 16 March 2015
+Since July 2016

View citations on PubMed Central and Google Scholar